Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Strontium malonate dose-response study in postmenopausal women with low bone mineral density
2006-003615-40Phase 2Completed
- Sponsor
- Osteologix
- Start
- Sep 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of strontium malonate in postmenopausal osteoporosis (5 arms), sponsored by Osteologix. Primary endpoint: Change in S-CTX-1 from baseline to week 12. Started Sep 2006; status: completed.
02
Drugs
strontium malonate
03
Conditions
postmenopausal osteoporosis
Beyond the preview
Go deeper on 2006-003615-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-003615-40.